MAPT and frontotemporal dementia: QC-01-175, a small-molecule tau-degrading PROTAC based on the PET tracer T807, with a CRBN ligand, was shown to induce Tau degradation in FTD patient-derived neuronal models including the tau-A152T and the tau-P301L variants [198].